PDL BioPharma up for sale

PDL BioPharma Inc. (PDL) is actively seeking offers for the sale of the company as a whole or of its key assets following a review of its strategic alternatives.

In conjunction with the announcement of the potential sale on Monday, CEO and director Mark McDade also stepped down immediately. The company’s board elected former chairperson of the board L. Patrick Gage as interim CEO and Karen A. Dawes as the new chairperson of the board.

The company has said it is relocating from Fremont to Redwood City this fall.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Tenderloin merchants, residents come together over street closures

Parts of Larkin, Golden Gate to close four days a week to promote outdoor business, dining

Enter ‘The Matrix’: Drive-in movies during a pandemic

Though it’s fun to take in a film and drink, I miss watching bartenders make cocktails

Twin Peaks closure leads to complaints from neighbors

Twin Peaks Boulevard will no longer be entirely closed to motor vehicles… Continue reading

David Kubrin on Marxism and magic in the Mission

Former academic, industrial designer pens book on alternative, or people’s, science

Fire danger high in North and East Bay as region enters another hot, dry weekend

Spare the Air Alert issued for Sunday as heat, smoke and fumes expected to increase

Most Read